BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jodeleit H, Milchram L, Soldo R, Beikircher G, Schönthaler S, Al-Amodi O, Wolf E, Beigel F, Weinhäusel A, Siebeck M, Gropp R. Autoantibodies as diagnostic markers and potential drivers of inflammation in ulcerative colitis. PLoS One 2020;15:e0228615. [PMID: 32050001 DOI: 10.1371/journal.pone.0228615] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Dai Y, Lu Q, Li P, Zhu J, Jiang J, Zhao T, Hu Y, Ding K, Zhao M. Xianglian Pill attenuates ulcerative colitis through TLR4/MyD88/NF-κB signaling pathway. Journal of Ethnopharmacology 2023;300:115690. [DOI: 10.1016/j.jep.2022.115690] [Reference Citation Analysis]
2 Ma H, Murphy C, Loscher CE, O’kennedy R. Autoantibodies - enemies, and/or potential allies? Front Immunol 2022;13:953726. [DOI: 10.3389/fimmu.2022.953726] [Reference Citation Analysis]
3 Lee SM, Park KH, Joo E, Jeong DE, Lee JE, Lee KN, Shin S. High-throughput analysis of amniotic fluid proteins associated with histological chorioamnionitis in preterm premature rupture of membranes using an antibody-based microarray. Am J Reprod Immunol 2022;:e13595. [PMID: 35792516 DOI: 10.1111/aji.13595] [Reference Citation Analysis]
4 Kny E, Reiner-rozman C, Dostalek J, Hassel A, Nöhammer C, Pfaffeneder-mantai F, Szunerits S, Weber V, Knoll W, Kleber C. State of the Art of Chemosensors in a Biomedical Context. Chemosensors 2022;10:199. [DOI: 10.3390/chemosensors10060199] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Unterweger AL, Jensen MØ, Giordanetto F, Jogini V, Rüschher A, Seuß M, Winkelmann P, Koletzko L, Shaw DE, Siebeck M, Gropp R, Beigel F, Aszodi A. Suppressing Kv1.3 Ion Channel Activity with a Novel Small Molecule Inhibitor Ameliorates Inflammation in a Humanized Mouse Model of Ulcerative Colitis. J Crohns Colitis 2021:jjab078. [PMID: 33891001 DOI: 10.1093/ecco-jcc/jjab078] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Jodeleit H, Winkelmann P, Caesar J, Sterz S, Holdt LM, Beigel F, Stallhofer J, Breiteneicher S, Bartnik E, Leeuw T, Siebeck M, Gropp R. Head-to-head study of oxelumab and adalimumab in a mouse model of ulcerative colitis based on NOD/Scid IL2Rγnull mice reconstituted with human peripheral blood mononuclear cells. Dis Model Mech 2021;14:dmm046995. [PMID: 33293281 DOI: 10.1242/dmm.046995] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]